FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,538 | -52.7% | 11,157 | -64.9% | 0.00% | – |
| Q2 2023 | $104,804 | +8575.8% | 31,759 | +7390.3% | 0.00% | – |
| Q1 2023 | $1,208 | -95.6% | 424 | -88.8% | 0.00% | – |
| Q4 2022 | $27,584 | -21.2% | 3,789 | +157.9% | 0.00% | – |
| Q1 2022 | $35,000 | +133.3% | 1,469 | +78.1% | 0.00% | – |
| Q4 2021 | $15,000 | -59.5% | 825 | -36.8% | 0.00% | – |
| Q3 2021 | $37,000 | +270.0% | 1,305 | +38.5% | 0.00% | – |
| Q2 2021 | $10,000 | -44.4% | 942 | -38.1% | 0.00% | – |
| Q1 2021 | $18,000 | +350.0% | 1,521 | +360.9% | 0.00% | – |
| Q4 2020 | $4,000 | -84.6% | 330 | -89.8% | 0.00% | – |
| Q3 2020 | $26,000 | -67.1% | 3,226 | -25.7% | 0.00% | – |
| Q2 2020 | $79,000 | -18.6% | 4,340 | -46.5% | 0.00% | – |
| Q1 2020 | $97,000 | -4.0% | 8,113 | +32.8% | 0.00% | – |
| Q4 2019 | $101,000 | +248.3% | 6,107 | +37.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 4,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |